EUVIMEDEUVIMED entdecken
Open Access

Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response

Naoko Sekiguchi, Hidenori Takahashi, Shogo Kobayashi, Kazuki Sasaki, Shinichiro Hasegawa, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu und 4 weitere

International Journal of Oncology · 2026

DOI: 10.3892/ijo.2026.5849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2026. Verfasst von Naoko Sekiguchi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565‑0871, Japan. Hauptthemen laut MEDLINE: Deoxycytidine, Pancreatic Neoplasms, Drug Resistance, Neoplasm, Biomarkers, Tumor. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxycytidinePancreatic NeoplasmsDrug Resistance, NeoplasmBiomarkers, TumorRNA, CircularAntimetabolites, AntineoplasticHumansGemcitabineMaleFemaleCell Line, TumorMiddle AgedAgedGene Expression Regulation, NeoplasticPrognosisEquilibrative Nucleoside Transporter 1ApoptosisNeoadjuvant Therapy

Stichwörter der Autor:innen

RNAbiomarkerscirculargemcitabinepancreatic neoplasms

Substanzen

GemcitabineDeoxycytidineBiomarkers, TumorRNA, CircularAntimetabolites, AntineoplasticEquilibrative Nucleoside Transporter 1SLC29A1 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565‑0871, Japan.
  • Center for Comprehensive Genomic Medicine, Okayama University Hospital, Kita‑Ku, Okayama 700‑8558, Japan.

Zitieren

APA

Sekiguchi, N., Takahashi, H., Kobayashi, S., Sasaki, K., Hasegawa, S., Iwagami, Y., Yamada, D., Tomimaru, Y., Akita, H., Asaoka, T., Noda, T., Shimizu, J., Tanaka, K., Chijimatsu, R., Doki, Y., & Eguchi, H. (2026). Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response. International Journal of Oncology. https://doi.org/10.3892/ijo.2026.5849

Vancouver

Sekiguchi N, Takahashi H, Kobayashi S, Sasaki K, Hasegawa S, Iwagami Y, et al. Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response. International Journal of Oncology. 2026. doi:10.3892/ijo.2026.5849

BibTeX
@article{Sekiguchi2026,
  author = {Sekiguchi, Naoko and Takahashi, Hidenori and Kobayashi, Shogo and Sasaki, Kazuki and Hasegawa, Shinichiro and Iwagami, Yoshifumi and Yamada, Daisaku and Tomimaru, Yoshito and Akita, Hirofumi and Asaoka, Tadafumi and Noda, Takehiro and Shimizu, Junzo and Tanaka, Koji and Chijimatsu, Ryota and Doki, Yuichiro and Eguchi, Hidetoshi},
  title = {Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response},
  journal = {International Journal of Oncology},
  year = {2026},
  doi = {10.3892/ijo.2026.5849}
}
Kostenlos starten →